Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether adding tirofiban, administered at high bolus dose on top of
aspirin and clopidogrel will lead to a lower rate of periprocedural myocardial infarction
after percutaneous coronary intervention in elective patients presenting with aspirin and/or
clopidogrel resistance.